Professor Neil Guha

Professor Neil Guha

Queens Medical Centre Campus, Derby Road, Nottingham, NG7 2UH

+44 115 924 9924 Ext 70609 View full bio
Clinical Associate Professor in Hepatology

Dr Neil Guha is a Clinical Associate Professor in Hepatology at the University of Nottingham. He trained at Guy’s and St. Thomas’s hospitals and began his postgraduate career in hepatology at St. Mary’s Hospital, London. His doctoral thesis, awarded by the University of Southampton, focussed on non-invasive biomarkers of liver fibrosis. He completed his clinical training at the Southampton Liver Unit and was appointed as a clinical lecturer by the University of Southampton in 2008. He moved to Nottingham in 2009 to commence his current post at the National Institute of Health Research Nottingham Digestive Diseases Centre Biomedical Research Unit. His research continues to focus on biomarkers of liver fibrosis with current work in serum markers, hypothesis generating technologies, imaging modalities and utilisation of biomarkers in clinical practice.

Publications
Title
Prediction, prevention and management of postresection liver failure
Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Di
Late diagnosis of chronic liver disease in a community cohort (UK biobank): determinants and impact
Obesity Is the Most Common Risk Factor for Chronic Liver Disease: Results From a Risk Stratification
Noninvasive Assessment of Liver Fibrosis: Serum Markers, Imaging, and Other Modalities
Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hep
gamma-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular di
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steato
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European liver f
Validation of a novel biomarker model for the prediction for non-alcholic steatohepatitis in patient
Performance characteristics of unsedated ultrathin video endoscopy in the assessment of the upper GI
Antibiotic prophylaxis in variceal hemorrhage: timing, effectiveness and associated Clostridium diff
The effects of terlipressin and direct portocaval shunting on liver haemodynamics following 80% hepa
Back to the Future with Noninvasive Biomarkers of Liver Fibrosis
Antibiotic prophylaxis in variceal hemorrhage: Timing, effectiveness and Clostridium difficile rates
Non-invasive monitoring of liver fibrosis
Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Di
Genome-wide Association Study for Alcohol-related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPU
Consistent Beneficial Effects of Killer Cell Immunoglobulin-Like Receptor 2DL3 and Group 1 Human Leu
Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus:
Validation of a Model for Identification of Patients With Compensated Cirrhosis at High Risk of Deco
Non-invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Ty
Biomarkers of Liver Fibrosis: What Lies Beneath the Receiver Operating Characteristic Curve?
Metabolic phenotyping for enhanced mechanistic stratification of chronic hepatitis C-induced liver f
The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk
Prevalence of clinically significant liver disease within the general population, as defined by non-
The effects of terlipressin and direct portacaval shunting on liver hemodynamics following 80% hepat
Comparison of the reverse bevel versus Franseen type endoscopic ultrasound needle
Performance characteristics of unsedated ultrathin video endoscopy in the assessment of the upper GI
Obesity Is the Most Common Risk Factor for Chronic Liver Disease: Results From a Risk Stratification
Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis i
Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospec
Detecting chronic liver disease: are liver function tests the solution?
SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosi
Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic s
The effect of prone positioning with surgical bolsters on liver blood flow in healthy volunteers
Analysis of genotyping for predicting liver injury marker, procollagen III in persons at risk of non
Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fat
Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primar
The Road to a Successful Transjugular Intrahepatic Portosystemic Shunt (Tips) Service: Experience of
Acceptability of chronic liver disease screening in a UK primary care setting: a qualitative evaluat
The evaluation of portal hypertension using quantitative magnetic resonance imaging (MRI)
Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging
A study of T1 relaxation time as a measure of liver fibrosis and the influence of confounding histol
Visual morphometry and three non-invasive markers in the evaluation of liver fibrosis in chronic liv
Analysis of genotyping for predicting liver injury marker, Procollagen III in persons at risk of non
The detection of oesophageal varices using a novel, disposable, probe-based transnasal endoscope: a
The detection of oesophageal varices using a novel, disposable, probe-based transnasal endoscope: a